NCT05896566 2026-02-24
PREcoopERA
ETOP IBCSG Partners Foundation
Phase 2 Completed
Clinical Trials
8 trialsNCT05982093 2025-05-22
SOLTI-2104
SOLTI Breast Cancer Research Group
Phase 2 Active not recruiting
NCT03944434 2025-02-26
FACILE
Fondazione Sandro Pitigliani
Phase 2 Active not recruiting
NCT02113553 2022-09-10
Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve
Istituto Clinico Humanitas
Phase 2 Terminated
NCT00090844 2021-01-28
Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer
University of South Florida
Phase 2 Terminated
NCT04659551 2020-12-09
GIADA
Istituto Oncologico Veneto IRCCS
Phase 2 Completed
NCT02005887 2019-05-29
TREND
ETOP IBCSG Partners Foundation
Phase 2 Completed
NCT00194792 2017-07-11
Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer
University of Washington
Phase 2 Terminated